TipRanks
Advertisement

CRCA ETF Price & Analysis

Compare

CRCA ETF Chart & Stats

17.40
--
Market closed
17.40
--

ETF Overview

ProShares Ultra CRCL

ProShares Ultra CRCL (CRCA) is an innovative exchange-traded fund (ETF) designed for investors seeking amplified exposure to the dynamic Information Technology sector, specifically within the Application Software niche. This ETF aims to deliver twice the daily performance of the Circle Internet Group (CRCL), before accounting for fees and expenses. By focusing on a leveraged strategy, CRCA offers sophisticated investors the opportunity to capitalize on short-term movements and trends within the rapidly evolving application software market. With its concentrated approach, ProShares Ultra CRCL is tailored for those with a high-risk tolerance looking to enhance their returns by tapping into the potential growth of cutting-edge technology companies driving innovation in the digital space.

ProShares Ultra CRCL (CRCA) Fund Flow Chart

ProShares Ultra CRCL (CRCA) 1 year Net Flows: 93M

CRCA ETF FAQ

What was CRCA’s price range in the past 12 months?
CRCA lowest ETF price was 10.07 and its highest was 204.45 in the past 12 months.
    What is the AUM of CRCA?
    As of Sep 30, 2026 The AUM of CRCA is 103.99M.
      Is CRCA overvalued?
      Not enough analysts have published a price target to calculate whether the price is overvalued.
      Does CRCA pay dividends?
      CRCA pays a Quarterly dividend of 0.126 which represents an annual dividend yield of 4.57%. See more information on CRCA dividends here
        How many shares outstanding does CRCA have?
        Currently, no data Available
        Which hedge fund is a major shareholder of CRCA?
        Currently, no hedge funds are holding shares in CRCA
        Popular ETFs
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Advertisement